Applications of 2-Bromo-1-(3,4-Dihydro-2H-1,5-Benzodioxepin-7-Yl)Ethan-1-One in Industrial Manufacturing

As an established manufacturer of high-purity specialty chemicals, we supply 2-Bromo-1-(3,4-Dihydro-2H-1,5-Benzodioxepin-7-Yl)Ethan-1-One to a concentrated set of downstream sectors. The following application segments detail typical standards, concentration parameters, production staging, and real-world finished products enabled by this intermediate.

1. Pharmaceutical Intermediate for CNS Active Compounds

This compound serves in the synthesis of advanced intermediates for central nervous system (CNS) pharmaceuticals, particularly for benzodioxepin-derived drug scaffolds. Manufacturers use it to build core frameworks for patented novel small molecules targeting anxiety, mood stabilization, or cognitive disorders. Typical applications demand trace impurity control and documented batch consistency aligned with regulated clinical development or commercial production settings.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP General Chapter <797> and <823> as applicable for radiopharmaceutical handling
• FDA 21 CFR Part 210 and 211 for finished pharmaceuticals
• European Pharmacopoeia monographs for CNS actives (as required by MAH)

Typical usage ratio

• Batch synthesis: 0.7–1.3 molar ratio as per route optimization for heterocyclic ring construction; adjusted for impurity profile and downstream yield targeting.

Downstream process integration

• Added following ring closure steps and prior to amide/amine substitution stages
• Integrated in multi-step syntheses proceeding via nucleophilic displacement
• Used in continuous flow or batch reactors depending on reaction scale
• Subjected to strict in-process control by HPLC and NMR for API development

Final product types

• Clinical trial APIs for CNS indications
• Commercial CNS small molecule APIs
• Precursor for key intermediates in antidepressant and anxiolytic medication manufacture
• Specialty research chemicals for pharmacological tool compounds

2. Agrochemical Building Block for Fungicide Synthesis

Major agrochemical producers utilize this molecule in the synthesis of active ingredients for protective fungicide products targeting high-value crops. Its brominated side-chain enables functionalization in multi-step processes, often providing increased efficacy and specificity for custom benzodioxepin constructs evaluated for regulatory approval under local and global crop-protection legislation.

Industry compliance standards

• OECD Guidelines for the Testing of Chemicals
• REACH Registration, Evaluation, Authorisation and Restriction of Chemicals
• EPA FIFRA (Federal Insecticide, Fungicide, and Rodenticide Act) regulations
• Japan FAMIC and equivalent national agrochemical registration systems

Typical usage ratio

• 1.0–2.5 molar equivalents in the key substitution or coupling step; refined during lead optimization based on target yield and toxicity screening.

Downstream process integration

• Used in the starting stage for etherification or acylation reactions
• Feeds into bromine-displacement routes for ring closure or side-chain elaboration
• Subjected to stringent residual solvent and heavy metal controls per agrochemical QA/QC standards
• Supports pilot plant scale-up and regulatory batch submissions

Final product types

• Systemic and contact fungicide active ingredients
• Seed treatment formulation actives
• Pilot scale intermediates for patented agrochemicals
• Analytical reference substances for residue studies

3. Chemical Intermediate in Advanced Polymer Modification

Polymer additives and specialty resin manufacturers incorporate this intermediate to introduce benzodioxepin units in engineered plastic formulations. The product’s unique aromatic and functionalized structure supports the synthesis of high-performance polymers for demanding applications such as electronic encapsulants, automotive coatings, and UV-resistant films, where precise control of reactivity and material compatibility is crucial.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for manufacturing consistency
• RoHS Directive (Restriction of Hazardous Substances) compliance for electronics
• ASTM D256 and D638 for material property benchmarking
• UL 94 for flammability testing of plastics

Typical usage ratio

• Typically 0.5–2.2% by weight relative to total monomer input, adjusted for mechanical, optical, and processability properties required by the final specification.

Downstream process integration

• Charged as a co-monomer during melt-phase or solution polymerization steps
• Used in upstream additive blending and downstream chain end-modification
• Monitored for compatibility with standard extrusion and molding parameters
• Subjected to off-gas and extractables testing per end-use regulations

Final product types

• UV-stabilized engineering plastics for electronics
• Performance coatings for automotive and aerospace applications
• Advanced composite materials for structural parts
• Optically clear films resistant to photo-degradation

4. Custom Fine Chemical Synthesis for Analytical Reagents

Certified analytical laboratories and reagent suppliers use this molecule when synthesizing custom derivatization agents and calibration standards. The core structure supports the creation of specific labeling compounds for advanced LC-MS, HPLC, and NMR techniques, typically when a precise fingerprint or detection marker is essential for trace-level quantification and system suitability assessments in regulated settings.

Industry compliance standards

• ISO/IEC 17025 Accreditation Requirements for Testing and Calibration Laboratories
• USP <621> Chromatography system suitability requirements
• OECD GLP (Good Laboratory Practice) for analytical method validation
• ISO Guide 34 for reference material producers

Typical usage ratio

• Typically 80–200 mg/L in custom reagent synthesis, precisely calculated from analytical response and matrix compatibility requirements.

Downstream process integration

• Introduced as a derivatization or labeling agent precursor after protective group removal
• Incorporated at the synthesis of HPLC grade standards for system qualification
• Handled in ISO Class 8 cleanrooms to prevent contaminant carryover
• Packaged under argon or nitrogen to ensure stability for global distribution

Final product types

• Certified analytical standards (primary and secondary)
• Custom LC-MS derivatization agents
• NMR reference markers
• Traceability controls for regulatory testing